Trial Profile

Trial of BioGaia's Lactobacillus reuteri Protectis drops in infants with colic in China

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 30 Apr 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Limosilactobacillus reuteri (Primary)
Indications Colic
Focus Therapeutic Use

Most Recent Events

30 Apr 2015 New trial record
27 Apr 2015 Results published online in Antonie van Leeuwenhoek on 16 Apr 2015, according to a BioGaia media release.
27 Apr 2015 This study is the fifth positive colic study with Lactobacillus reuteri Protectis and the results confirm the positive results of earlier studies, according to a BioGaia media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com